Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2026 57.47M
June 30, 2026 57.45M
March 31, 2026 57.30M
December 31, 2025 57.14M
September 30, 2025 56.94M
June 30, 2025 56.89M
March 31, 2025 56.68M
December 31, 2024 56.64M
September 30, 2024 56.52M
June 30, 2024 56.41M
March 31, 2024 52.53M
December 31, 2023 51.65M
September 30, 2023 51.64M
June 30, 2023 36.53M
March 31, 2023 36.51M
December 31, 2022 36.43M
September 30, 2022 36.37M
Date Value
June 30, 2022 36.32M
March 31, 2022 36.29M
December 31, 2021 36.23M
September 30, 2021 36.23M
June 30, 2021 36.21M
March 31, 2021 36.15M
December 31, 2020 36.08M
September 30, 2020 35.96M
June 30, 2020 35.91M
March 31, 2020 35.91M
December 31, 2019 35.91M
September 30, 2019 35.91M
June 30, 2019 35.91M
March 31, 2019 35.91M
December 31, 2018 35.91M
September 30, 2018 35.91M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Lineage Cell Therapeutics, Inc. 252.91M
Armata Pharmaceuticals, Inc. 37.19M
Voyager Therapeutics, Inc. 62.17M
Invivyd, Inc. 295.63M
Elicio Therapeutics, Inc. 28.31M